A detailed history of True Private Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, True Private Wealth Advisors holds 31,518 shares of ABBV stock, worth $5.41 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
31,518
Previous 37,428 15.79%
Holding current value
$5.41 Million
Previous $5.8 Million 1.05%
% of portfolio
0.67%
Previous 0.74%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$159.82 - $182.1 $944,536 - $1.08 Million
-5,910 Reduced 15.79%
31,518 $5.74 Million
Q4 2023

Jan 30, 2024

BUY
$137.6 - $154.97 $330,102 - $371,773
2,399 Added 6.85%
37,428 $5.8 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $210,003 - $243,109
1,572 Added 4.7%
35,029 $5.22 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $40,018 - $49,799
-302 Reduced 0.89%
33,457 $4.51 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $76,643 - $88,266
530 Added 1.59%
33,759 $5.38 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $62,792 - $75,304
454 Added 1.39%
33,229 $5.37 Million
Q3 2022

Nov 04, 2022

BUY
$134.21 - $153.93 $394,040 - $451,938
2,936 Added 9.84%
32,775 $4.4 Million
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $80,507 - $102,351
585 Added 2.0%
29,839 $4.57 Million
Q1 2022

May 09, 2022

SELL
$131.98 - $163.75 $1.17 Million - $1.45 Million
-8,833 Reduced 23.19%
29,254 $4.43 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $253,212 - $320,387
2,357 Added 6.6%
38,087 $5.16 Million
Q3 2021

Nov 05, 2021

SELL
$106.4 - $120.78 $65,116 - $73,917
-612 Reduced 1.68%
35,730 $3.85 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $143,927 - $160,343
1,368 Added 3.91%
36,342 $4.09 Million
Q1 2021

May 12, 2021

BUY
$102.3 - $112.62 $144,243 - $158,794
1,410 Added 4.2%
34,974 $3.79 Million
Q4 2020

Jan 11, 2021

SELL
$80.49 - $108.67 $1,931 - $2,608
-24 Reduced 0.07%
33,564 $3.6 Million
Q3 2020

Oct 09, 2020

SELL
$85.91 - $100.83 $48,625 - $57,069
-566 Reduced 1.66%
33,588 $2.94 Million
Q2 2020

Jul 07, 2020

BUY
$73.37 - $98.18 $43,875 - $58,711
598 Added 1.78%
34,154 $3.35 Million
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $1.84 Million - $2.78 Million
28,475 Added 560.42%
33,556 $2.56 Million
Q4 2019

Jan 27, 2020

SELL
$72.13 - $90.25 $32,314 - $40,432
-448 Reduced 8.1%
5,081 $449,000
Q3 2019

Oct 09, 2019

BUY
$62.98 - $75.72 $70,978 - $85,336
1,127 Added 25.6%
5,529 $418,000
Q2 2019

Aug 01, 2019

SELL
$65.7 - $83.98 $1,971 - $2,519
-30 Reduced 0.68%
4,402 $320,000
Q1 2019

Apr 25, 2019

SELL
$77.14 - $90.79 $134,917 - $158,791
-1,749 Reduced 28.3%
4,432 $357,000
Q4 2018

Jan 14, 2019

SELL
$77.85 - $96.01 $414,551 - $511,253
-5,325 Reduced 46.28%
6,181 $569,000
Q3 2018

Oct 18, 2018

SELL
$88.91 - $98.84 $61,347 - $68,199
-690 Reduced 5.66%
11,506 $0
Q2 2018

Jul 13, 2018

BUY
$89.78 - $106.23 $209,995 - $248,471
2,339 Added 23.73%
12,196 $1.13 Million
Q1 2018

Apr 25, 2018

BUY
$92.01 - $123.21 $13,617 - $18,235
148 Added 1.52%
9,857 $933,000
Q4 2017

Jan 19, 2018

BUY
$89.56 - $98.21 $400,512 - $439,195
4,472 Added 85.39%
9,709 $939,000
Q3 2017

Oct 27, 2017

BUY
$69.85 - $89.22 $29,546 - $37,740
423 Added 8.79%
5,237 $465,000
Q2 2017

Aug 07, 2017

BUY
N/A
4,814
4,814 $349,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track True Private Wealth Advisors Portfolio

Follow True Private Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.